Cronos Group Fails To File Timely Financials Due To Revenue Review

Cronos Group (TSX: CRON) (NASDAQ: CRON) filed its annual report this evening, also known as a 10-K with the Securities and Exchange Commission. However, the filing itself wasn’t complete – resulting in the firm filing what is known as an “NT 10-K,” which in layman terms is a notification of the inability to timely file an annual report by the issuer. The company now has until mid-March to file complete annual financial statements.

While a modified annual report was filed by Cronos Group, it lacked the key data that is to be contained within an annual report – the necessary financial data. This was missing, as per Cronos Group, due to “a continuing review by the Audit Committee of the Company’s Board of Directors, with the assistance of outside counsel and forensic accountants, of several bulk resin purchases and sales of products through the wholesale channel and the appropriateness of the recognition of revenue from those transactions.”

Essentially, Cronos Group is currently using forensic accountants to determine whether or not it was appropriate to recognize certain revenues that previously appeared on the company’s financial statements. Primarily, these sales occurred through the wholesale channels that Cronos Group has established. The company has until March 15 to rectify the issue and file a complete annual report with the SEC or face further consequences.

Cronos has indicated that it intends to file its financials within the allotted extension period, however can provide no guarantee that it will.

Cronos Group closed the regular session at $6.02 on the Nasdaq, and fell 6.48% in the extended session to $5.63.


Information for this analysis was found via Sedar and Cronos Group. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Snowline Gold: The Multi Billion Dollar Valley PEA

Euro Sun: Rovina Copper-Gold Project Secures Some Major Funding

Arizona Metals: The Disappointing Kay Mine Resource Estimate

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

Medipharm Labs and Cronos Group Sign Second Manufacturing Agreement

Medipharm Labs (TSX: LABS) and Cronos Group (TSX: CRON) (NASDAQ: CRON) have entered into their...

Thursday, September 19, 2019, 09:23:17 AM

Cronos Pays OSC $1.3 Million As Penalty For Accounting Fraud, Settles SEC Charges

A Capital Markets Tribunal panel yesterday accepted a settlement agreement between the Ontario Securities Commission...

Tuesday, October 25, 2022, 11:01:00 AM

Cronos Group Exits Its US Operations After Spending $300 Million To Acquire Them During Height Of Cannabis Bubble

Cronos Group (NASDAQ: CRON) announced on Wednesday that it will be closing down its existing US...

Thursday, June 1, 2023, 08:37:40 AM

Cronos Group: Analysts Expect Another Quarterly Loss For Q2

Cronos Group (TSX: CRON) announced that they will be reporting their second quarter financials before...

Wednesday, August 4, 2021, 03:50:00 PM

Cronos Group Announces 10.5% Investment Into US Operator PharmaCann

It appears that rules pertaining to ownership of US cannabis operations are loosening at the...

Monday, June 14, 2021, 08:06:24 AM